BETH ISRAEL DEACONESS MEDICAL CENTER, INC.;THE GENERAL HOSPITAL CORPORATION;THE BRIGHAM AND WOMEN'S HOSPITAL, INC.;THE BRIGHAM AND WOMEN'S HOSPITAL, INC
发明人:
THADHANI, RAVI,STOSSEL, THOMAS P.,LEE, PO-SHUN,KARUMANCHI, ANANTH
申请号：
CA2749985
公开号：
CA2749985C
申请日:
2009.01.23
申请国别(地区):
CA
年份:
2020
代理人:
摘要：
There is no shared technical feature among all of Groups 1-111. The sharedtechnical feature of Groups I and III is amethod for characterizing renal failure comp.pi.sing, inter alia, comparinglevels of gelsolin. However, this is not an improvementover the prior art of US 5260224A to Stossel et al. (9 Novemeber 1993；hereinafter "Stossel") that teaches the use of gelosin in thediagnosis and treatment of renal disease (abstract, col 6 In 7-13, col 6 In 43-54, col 3 In 8-13). The shared technical feature ofGroups Il and III is a method for characterizing renal failure comprising,inter alia, comparing levels of actin from the subject.However, this is not an improvment over the prior art of Stossel that teachesthe use of actin in the diagnosis and treatment of renaldisease (abstract, col 1 In 11-17, col 3 In 36-67； claimi).
